Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2010
Bevacizumab and everolimus in renal cancer: a rational way forward
Walter M Stadler, George Phillips, Daniel J George, et al.
Urologic Oncology
|
October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901
Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Cancer
|
November 8, 2008
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811
William Kevin Kelly, Susan Halabi, Aymen Elfiky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy
Robert W Ross, Judith Manola, Kristen Hennessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2005
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901
Walter M Stadler, Gary Rosner, Eric Small, et al.
Cancer
|
October 7, 2004
Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
Matthew R Smith, Judith Manola, Donald S Kaufman, et al.
JCO Oncology Practice
|
February 23, 2022
Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial
Hala T Borno, Li Zhang, Sylvia Zhang, et al.
BJU International
|
April 25, 2017
Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer
J Kellogg Parsons, John P Pierce, James Mohler, et al.
Pilot and Feasibility Studies
|
November 14, 2019
A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool
Hala T Borno, Brian M Bakke, Celia Kaplan, et al.
EMBO Molecular Medicine
|
December 28, 2020
MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling
Jiangbin Wu, Kadiam C Venkata Subbaiah, Feng Jiang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2010
Bevacizumab and everolimus in renal cancer: a rational way forward
Walter M Stadler, George Phillips, Daniel J George, et al.
Urologic Oncology
|
October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901
Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Cancer
|
November 8, 2008
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811
William Kevin Kelly, Susan Halabi, Aymen Elfiky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy
Robert W Ross, Judith Manola, Kristen Hennessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2005
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901
Walter M Stadler, Gary Rosner, Eric Small, et al.
Cancer
|
October 7, 2004
Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
Matthew R Smith, Judith Manola, Donald S Kaufman, et al.
JCO Oncology Practice
|
February 23, 2022
Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial
Hala T Borno, Li Zhang, Sylvia Zhang, et al.
BJU International
|
April 25, 2017
Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer
J Kellogg Parsons, John P Pierce, James Mohler, et al.
Pilot and Feasibility Studies
|
November 14, 2019
A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool
Hala T Borno, Brian M Bakke, Celia Kaplan, et al.
EMBO Molecular Medicine
|
December 28, 2020
MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling
Jiangbin Wu, Kadiam C Venkata Subbaiah, Feng Jiang, et al.
Page
of 4